Improving the reliability and reporting of genetic association studies

Drug and Alcohol Dependence

Volumn 132, Issue 3, 2013, Pages 411-413

  Munafò, Marcus R ^a   Gage, Suzanne H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Candidate gene; Genetics; Genome wide association; Replicability; STREGA

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ALCOHOLISM; BAYES THEOREM; COMT GENE; DRD2 GENE; DRUG DEPENDENCE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INFORMATION PROCESSING; MOLECULAR PATHOLOGY; NOTE; PHENOTYPIC VARIATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RELIABILITY; SCHIZOPHRENIA;

CANDIDATE GENE; GENETICS; GENOME-WIDE ASSOCIATION; REPLICABILITY; STREGA;

EDITORIAL POLICIES; GENETIC ASSOCIATION STUDIES; GUIDELINE ADHERENCE; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 84883550945     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.03.023     Document Type: Note

References (23)

1. Broer L., Lill C.M., Schuur M., Amin N., Roehr J.T., Bertram L., Ioannidis J.P., van Duijn C.M. Distinguishing true from false positives in genomic studies: p values. Eur. J. Epidemiol. 2013, 28:131-138.
2. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
3. Collins A.L., Kim Y., Sklar P., O'Donovan M.C., Sullivan P.F. Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. Psychol. Med. 2012, 42:607-616.
4. Costas J., Sanjuan J., Ramos-Rios R., Paz E., Agra S., Tolosa A., Paramo M., Brenlla J., Arrojo M. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophrenia Res. 2011, 127:22-27.
5. Estrada G., Fatjo-Vilas M., Munoz M.J., Pulido G., Minano M.J., Toledo E., Illa J.M., Martin M., Miralles M.L., Miret S., Campanera S., Bernabeu C., Navarro M.E., Fananas L. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiat. Scand. 2011, 123:485-492.
6. Flint J., Munafo M.R. The endophenotype concept in psychiatric genetics. Psychol. Med. 2007, 37:163-180.
7. Flint J., Munafo M.R. Candidate and non-candidate genes in behavior genetics. Curr. Opin. Neurobiol. 2013, 23:57-61.
8. Hart A.B., de Wit H., Palmer A.A. Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology 2012, 38:802-816.
9. Henquet C., Rosa A., Delespaul P., Papiol S., Fananas L., van Os J., Myin-Germeys I. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiat. Scand. 2009, 119:156-160.
10. Henquet C., Rosa A., Krabbendam L., Papiol S., Fananas L., Drukker M., Ramaekers J.G., van Os J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31:2748-2757.
11. Ioannidis J.P. Why most published research findings are false. PLoS Med. 2005, 2:e124.
12. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., Khoury M.J., Cohen B., Davey-Smith G., Grimshaw J., Scheet P., Gwinn M., Williamson R.E., Zou G.Y., Hutchings K., Johnson C.Y., Tait V., Wiens M., Golding J., van Duijn C., McLaughlin J., Paterson A., Wells G., Fortier I., Freedman M., Zecevic M., King R., Infante-Rivard C., Stewart A., Birkett N. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009, 6:e22.
13. Munafo M.R., Flint J. Replication and heterogeneity in gene×environment interaction studies. Int. J. Neuropsychopharmacol. 2009, 12:727-729.
14. Munafo M.R., Flint J. Dissecting the genetic architecture of human personality. Trends Cogn. Sci. 2011, 15:395-400.
15. Olfson E., Bierut L.J. Convergence of genome-wide association and candidate gene studies for alcoholism. Alcohol. Clin. Exp. Res. 2012, 36:2086-2094.
16. Prinz F., Schlange T., Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets?. Nat. Rev. Drug Discov. 2011, 10:712.
17. Stein J.L., Medland S.E., Vasquez A.A., Hibar D.P., Senstad R.E., Winkler A.M., Toro R., Appel K., Bartecek R., Bergmann O., Bernard M., Brown A.A., Cannon D.M., Chakravarty M.M., Christoforou A., Domin M., Grimm O., Hollinshead M., Holmes A.J., Homuth G., Hottenga J.J., Langan C., Lopez L.M., Hansell N.K., Hwang K.S., Kim S., Laje G., Lee P.H., Liu X., Loth E., Lourdusamy A., Mattingsdal M., Mohnke S., Maniega S.M., Nho K., Nugent A.C., O'Brien C., Papmeyer M., Putz B., Ramasamy A., Rasmussen J., Rijpkema M., Risacher S.L., Roddey J.C., Rose E.J., Ryten M., Shen L., Sprooten E., Strengman E., Teumer A., Trabzuni D., Turner J., van Eijk K., van Erp T.G., van Tol M.J., Wittfeld K., Wolf C., Woudstra S., Aleman A., Alhusaini S., Almasy L., Binder E.B., Brohawn D.G., Cantor R.M., Carless M.A., Corvin A., Czisch M., Curran J.E., Davies G., de Almeida M.A., Delanty N., Depondt C., Duggirala R., Dyer T.D., Erk S., Fagerness J., Fox P.T., Freimer N.B., Gill M., Goring H.H., Hagler D.J., Hoehn D., Holsboer F., Hoogman M., Hosten N., Jahanshad N., Johnson M.P., Kasperaviciute D., Kent J.W., Kochunov P., Lancaster J.L., Lawrie S.M., Liewald D.C., Mandl R., Matarin M., Mattheisen M., Meisenzahl E., Melle I., Moses E.K., Muhleisen T.W., Nauck M., Nothen M.M., Olvera R.L., Pandolfo M., Pike G.B., Puls R., Reinvang I., Renteria M.E., Rietschel M., Roffman J.L., Royle N.A., Rujescu D., Savitz J., Schnack H.G., Schnell K., Seiferth N., Smith C., Steen V.M., Valdes Hernandez M.C., Van den Heuvel M., van der Wee N.J., Van Haren N.E., Veltman J.A., Volzke H., Walker R., Westlye L.T., Whelan C.D., Agartz I., Boomsma D.I., Cavalleri G.L., Dale A.M., Djurovic S., Drevets W.C., Hagoort P., Hall J., Heinz A., Jack C.R., Foroud T.M., Le Hellard S., Macciardi F., Montgomery G.W., Poline J.B., Porteous D.J., Sisodiya S.M., Starr J.M., Sussmann J., Toga A.W., Veltman D.J., Walter H., Weiner M.W., Alzheimer's Disease Neuroimaging Initiative; EPIGEN Consortium; IMAGEN Consortium, Saguenay Youth Study Group, Bis J.C., Ikram M.A., Smith A.V., Gudnason V., Tzourio C., Vernooij M.W., Launer L.J., DeCarli C., Seshadri S., Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium, Andreassen O.A., Apostolova L.G., Bastin M.E., Blangero J., Brunner H.G., Buckner R.L., Cichon S., Coppola G., de Zubicaray G.I., Deary I.J., Donohoe G., de Geus E.J., Espeseth T., Fernandez G., Glahn D.C., Grabe H.J., Hardy J., Hulshoff Pol H.E., Jenkinson M., Kahn R.S., McDonald C., McIntosh A.M., McMahon F.J., McMahon K.L., Meyer-Lindenberg A., Morris D.W., Muller-Myhsok B., Nichols T.E., Ophoff R.A., Paus T., Pausova Z., Penninx B.W., Potkin S.G., Samann P.G., Saykin A.J., Schumann G., Smoller J.W., Wardlaw J.M., Weale M.E., Martin N.G., Franke B., Wright M.J., Thompson P.M., Enhancing Neuro Imaging Genetics through Meta-Analysis C. Identification of common variants associated with human hippocampal and intracranial volumes. Nat. Gen. 2012, 44:552-561.
18. Stephens M., Balding D.J. Bayesian statistical methods for genetic association studies. Nat. Rev. Gen. 2009, 10:681-690.
19. Sullivan P.F. Spurious genetic associations. Biol. Psychiatry 2007, 61:1121-1126.
20. van Winkel R. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch. Gen. Psychiatry 2011, 68:148-157.
21. Wray N.R., Visscher P.M. Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophrenia Bull. 2010, 36:14-23.
22. Zammit S., Owen M.J., Evans J., Heron J., Lewis G. Cannabis, COMT and psychotic experiences. Br. J. Psychiatry 2011, 199:380-385.
23. Zammit S., Spurlock G., Williams H., Norton N., Williams N., O'Donovan M.C., Owen M.J. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br. J. Psychiatry 2007, 191:402-407.